| scholarly article | Q13442814 |
| P50 | author | João Paulo Figueiró Longo | Q53084382 |
| P2093 | author name string | Ricardo Bentes Azevedo | |
| Beatriz Chiyin Ma | |||
| Luis Alexandre Muehlmann | |||
| Maria de Fátima Menezes Almeida Santos | |||
| P2860 | cites work | Development of a novel vaccine delivery system based on Gantrez nanoparticles | Q51117082 |
| Initiation of Apoptosis versus Necrosis by Photodynamic Therapy with Chloroaluminum Phthalocyanine | Q73805214 | ||
| High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status | Q80591642 | ||
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. | Q30845119 | ||
| Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives | Q31040847 | ||
| Photodynamic therapy for prostate cancer--a review of current status and future promise | Q33398502 | ||
| Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization | Q33939514 | ||
| A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. | Q33962996 | ||
| Photodynamic therapy and anti-tumour immunity. | Q34105703 | ||
| Photodynamic therapy for cancer | Q34194073 | ||
| Targeted photodynamic therapy via receptor mediated delivery systems | Q35620854 | ||
| Current clinical and preclinical photosensitizers for use in photodynamic therapy | Q35842442 | ||
| Drug targeting with nano-sized carrier systems | Q36226206 | ||
| Odyssey of a cancer nanoparticle: from injection site to site of action | Q36459196 | ||
| Photodynamic therapy-generated vaccines: relevance of tumour cell death expression | Q36610586 | ||
| Mechanisms of cell death in oxidative stress | Q36658125 | ||
| Molecular effectors of multiple cell death pathways initiated by photodynamic therapy | Q36907982 | ||
| The roles of therapy-induced autophagy and necrosis in cancer treatment | Q37038235 | ||
| Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy | Q37580050 | ||
| Activatable photosensitizers for imaging and therapy. | Q37682213 | ||
| Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity | Q37707162 | ||
| Tumor delivery of macromolecular drugs based on the EPR effect | Q37715368 | ||
| Nanodrug applications in photodynamic therapy | Q37844844 | ||
| Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy | Q37942172 | ||
| Nanophotosensitizers toward advanced photodynamic therapy of Cancer. | Q38047162 | ||
| Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells | Q39557319 | ||
| Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies | Q39766119 | ||
| Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. | Q40230892 | ||
| Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition | Q41486690 | ||
| Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. | Q41725866 | ||
| A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. | Q42521789 | ||
| Photodynamic therapy: novel third-generation photosensitizers one step closer? | Q43111267 | ||
| A new bioerodible system for sustained local drug delivery based on hydrolytically activated in situ macromolecular association | Q43277585 | ||
| Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates | Q44185143 | ||
| Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties | Q44403429 | ||
| Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. | Q45930946 | ||
| Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids | Q46407920 | ||
| Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles | Q46446246 | ||
| Salmonella-like bioadhesive nanoparticles | Q46560166 | ||
| In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome | Q46893035 | ||
| Bioadhesive properties of Gantrez nanoparticles | Q46897266 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aluminum | Q663 |
| nanoparticle | Q61231 | ||
| P304 | page(s) | 1199-1213 | |
| P577 | publication date | 2014-03-07 | |
| P1433 | published in | International Journal of Nanomedicine | Q6051502 |
| P1476 | title | Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy | |
| P478 | volume | 9 |
| Q52316502 | AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers |
| Q35683475 | Aluminium-phthalocyanine chloride nanoemulsions for anticancer photodynamic therapy: Development and in vitro activity against monolayers and spheroids of human mammary adenocarcinoma MCF-7 cells. |
| Q36302221 | Combined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacy |
| Q114774078 | Development of Biotechnological Photosensitizers for Photodynamic Therapy: Cancer Research and Treatment—From Benchtop to Clinical Practice |
| Q59795880 | Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel |
| Q52650354 | Investigations on the antitumor activity of classical trifluoro-substituted zinc phthalocyanines derivatives |
| Q39138277 | Mechanistics and photo-energetics of macrocycles and photodynamic therapy: An overview of aspects to consider for research |
| Q49593477 | Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro. |
| Q47097576 | Nanomedicine associated with photodynamic therapy for glioblastoma treatment |
| Q26765475 | Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review |
| Q38657626 | Natural extracellular nanovesicles and photodynamic molecules: is there a future for drug delivery? |
| Q34123491 | Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma |
| Q38642278 | SERS Investigation of Cancer Cells Treated with PDT: Quantification of Cell Survival and Follow-up. |
| Q51737861 | Simple and Selective HPLC-UV/Vis Bioanalytical Method to Determine Aluminum Phthalocyanine Chloride in Skin Permeation Studies. |
| Q89094424 | Synthesis and Evaluation of New Potential Benzo[a]phenoxazinium Photosensitizers for Anticancer Photodynamic Therapy |
Search more.